Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users.
作者信息
Swan Tracy, Curry Jen
出版信息
Hepatology. 2009 Jul;50(1):323-4; author reply 324-5. doi: 10.1002/hep.23077.
PMID:19554546
Abstract
摘要
相似文献
1
Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users.关于美国肝病研究学会（AASLD）丙型肝炎诊断、管理及治疗更新实践指南的评论：治疗活跃吸毒者
Hepatology. 2009 Jul;50(1):323-4; author reply 324-5. doi: 10.1002/hep.23077.
2
Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelines.丙型肝炎病毒2型或3型患者的管理：对美国肝病研究协会更新的实践指南的评论
Hepatology. 2009 Jul;50(1):323; author reply 324-5. doi: 10.1002/hep.23038.
3
[Diagnosis and treatment of acute and chronic hepatitis C--procedure in difficult situations].[急慢性丙型肝炎的诊断与治疗——困难情况下的诊疗流程]
Z Gastroenterol. 2004 Aug;42(8):720-3. doi: 10.1055/s-2004-813445.
4
Treatment of hepatitis C in injection drug users.
Am J Gastroenterol. 2005 Jan;100(1):5-7. doi: 10.1111/j.1572-0241.2005.41294.x.
5
[Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network].丙型肝炎病毒感染以及儿童和青少年病毒感染的诊断、进展与治疗——德国消化代谢疾病学会循证共识会议及与肝炎专业网络合作的结果
Z Gastroenterol. 2004 Aug;42(8):703-4. doi: 10.1055/s-2004-813441.
6
KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.美国肾脏疾病改善全球预后组织（KDOQI）对改善全球肾脏病预后组织（KDIGO）慢性肾脏病丙型肝炎预防、诊断、评估及治疗临床实践指南的评论
Am J Kidney Dis. 2008 Nov;52(5):811-25. doi: 10.1053/j.ajkd.2008.08.005.
7
AAP releases hepatitis C screening recommendations.美国儿科学会发布丙型肝炎筛查建议。
Am Fam Physician. 1998 Oct 1;58(5):1218.
8
[Definition and diagnosis of acute and chronic hepatitis C].[急性和慢性丙型肝炎的定义与诊断]
Z Gastroenterol. 2004 Aug;42(8):705-6. doi: 10.1055/s-2004-813442.
9
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?不给非法药物使用者治疗丙型肝炎是否合理？
N Engl J Med. 2001 Jul 19;345(3):211-5. doi: 10.1056/NEJM200107193450311.
10
[Criteria for the definition of acute and chronic hepatitis C].[急性和慢性丙型肝炎的定义标准]
Z Gastroenterol. 2004 Aug;42(8):707-13. doi: 10.1055/s-2004-813443.
引用本文的文献
1
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.针对丙型肝炎病毒2/3型感染的注射吸毒者，采用响应引导的聚乙二醇化干扰素和利巴韦林治疗的依从性：ACTIVATE研究。
BMC Infect Dis. 2017 Jun 13;17(1):420. doi: 10.1186/s12879-017-2517-3.
2
Characteristics and impact of methamphetamine use in patients with chronic hepatitis C.甲基苯丙胺使用对慢性丙型肝炎患者的特征和影响。
J Addict Med. 2014 Jan-Feb;8(1):25-32. doi: 10.1097/ADM.0000000000000001.
3
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.新近感染丙型肝炎病毒（HCV）的注射吸毒者对治疗的依从性。
J Hepatol. 2011 Jul;55(1):76-85. doi: 10.1016/j.jhep.2010.10.033. Epub 2010 Nov 23.
Zotero 插件